T-group (topology)
101.1.10 Cyclin-like
Ligands and drugs
4,079
Member domains
440
with ligand contacts (≤ 4 Å)
10.8% of members
318
with DrugDomain annotations
7.8% of members
268
with a DrugBank compound
6.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 101.1.10 belongs to X-group 101 HTH, which binds 8.7 ligand superclasses per 20 proteins, broader than 73% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03864 | SGM | Monothioglycerol | 61 |
| DB04447 | DTT | 1,4-Dithiothreitol | 4 |
| DB00945 | — | Acetylsalicylic acid | 2 |
| DB01169 | — | — | 2 |
| DB01692 | DTU | Dithioerythritol | 2 |
| DB02091 | — | 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine | 2 |
| DB02407 | — | 6-O-Cyclohexylmethyl Guanine | 2 |
| DB02833 | — | [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine | 2 |
| DB02915 | — | 4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine | 2 |
| DB06844 | — | 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE | 2 |
| DB06944 | — | N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide | 2 |
| DB06948 | — | 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE | 2 |
| DB07126 | — | O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE | 2 |
| DB07137 | — | (2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide | 2 |
| DB07164 | — | N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine | 2 |
| DB07203 | — | 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE | 2 |
| DB07471 | — | 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE | 2 |
| DB07533 | — | 4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]-2-Furyl}-N-Methylbenzenesulfonamide | 2 |
| DB07534 | — | 4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]furan-2-Yl}benzenesulfonamide | 2 |
| DB07538 | — | 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SGM | MONOTHIOGLYCEROL | 70 |
| MGmetal | MAGNESIUM ION | 31 |
| ZNmetal | ZINC ION | 11 |
| NAmetal | SODIUM ION | 7 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 4 |
| IJF | (4-bromanylpyridin-2-yl)methanol | 4 |
| UU1 | 2-(4-bromo-1H-pyrazol-1-yl)ethan-1-ol | 4 |
| 1P8 | 6-bromo-1,3-dihydro-2H-indol-2-one | 3 |
| CL | CHLORIDE ION | 3 |
| HHT | 2-(4-bromanyl-2-methoxy-phenyl)ethanoic acid | 3 |
| UUG | (4-bromo-2-methoxyphenyl)methanol | 3 |
| 3Z7 | 4-bromo-2-methoxyphenol | 2 |
| A1AC4 | (8R)-N-[(2S,3R)-3-(cyclohexylmethoxy)-1-(morpholin-4-yl)-1-oxobutan-2-yl]-2-[(1S)-2,2-dimethylcyclopropane-1-carbonyl]-6-(1,3-thiazole-5-carbonyl)-2,6-diazaspiro[3.4]octane-8-carboxamide | 2 |
| A1AC5 | (8R)-6-(1-benzyl-1H-pyrazole-4-carbonyl)-N-[(2S,3R)-3-(2-cyclohexylethoxy)-1-(methylamino)-1-oxobutan-2-yl]-2-[(1S)-2,2-dimethylcyclopropane-1-carbonyl]-2,6-diazaspiro[3.4]octane-8-carboxamide | 2 |
| A1H6X | 4-iodanylbenzenesulfonamide | 2 |
| BYZ | 4-bromo-1H-pyrazole | 2 |
| C35 | N~2~-{[1-(4-CHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOL-3-YL]CARBONYL}-N~5~-(DIAMINOMETHYLIDENE)-L-ORNITHYL-L-LEUCYL-L-ISOLEUCYL-4-FLUORO-L-PHENYLALANINAMIDE | 2 |
| DTU | (2R,3S)-1,4-DIMERCAPTOBUTANE-2,3-DIOL | 2 |
| GVC | 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID | 2 |
| HEW | 4-bromanylpyridin-2-amine | 2 |